Evidence for the complexity of Microrna-Mediated regulation in ovarian cancer: A systems approach

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Shahab, Shubin W ^a   Matyunina, Lilya V ^a,b   Mezencev, Roman ^a,b   de Walker, L Ette ^a,b   Bowen, Nathan J ^b,c   Benigno, Benedict B ^b   McDonald, John F ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Ovarian Cancer Institute   (United States)

^c CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ARTICLE; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; OVARY CANCER; PREDICTION; REGULATORY MECHANISM; TISSUE MICROARRAY; UPREGULATION; ADULT; AGED; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; SYSTEMS BIOLOGY; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CLUSTER ANALYSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS; RNA, MESSENGER; SYSTEMS BIOLOGY; TRANSFECTION; UP-REGULATION;

EID: 79960648178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022508     Document Type: Article

References (75)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
3. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
4. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
5. Pillai RS, Bhattacharyya SN, Filipowicz W, (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-126.
6. Tang G, Tang X, Mendu V, Jia X, Chen QJ, et al. (2008) The art of microRNA: various strategies leading to gene silencing via an ancient pathway. Biochim Biophys Acta 1779: 655-662.
7. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.
8. Hammond SM, (2006) MicroRNA therapeutics: a new niche for antisense nucleic acids. Trends Mol Med 12: 99-101.
9. Tong AW, Nemunaitis J, (2008) Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355.
10. Nam S, Li M, Choi K, Balch C, Kim S, et al. (2009) MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res 37: W356-362.
11. Ruike Y, Ichimura A, Tsuchiya S, Shimizu K, Kunimoto R, et al. (2008) Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet 53: 515-523.
12. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N, (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A 103: 2746-2751.
13. Wang YP, Li KB, (2009) Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC Genomics 10: 218.
14. Xin F, Li M, Balch C, Thomson M, Fan M, et al. (2009) Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics 25: 430-434.
15. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih Ie M, et al. (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3: e2436.
16. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707.
17. Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, et al. (2009) Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4: e5311.
18. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433.
19. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103: 9136-9141.
20. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
21. Min H, Yoon S, (2010) Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med 42: 233-244.
22. Saito T, Saetrom P, (2010) MicroRNAs-targeting and target prediction. N Biotechnol 27: 243-249.
23. Auersperg N, (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30: 12-21.
24. Griffiths-Jones S, (2004) The microRNA Registry. Nucleic Acids Res 32: D109-111.
25. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
26. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
27. da Costa LF, (2001) Return of de-differentiation: why cancer is a developmental disease. Curr Opin Oncol 13: 58-62.
28. Diaz-Cano SJ, (2008) General morphological and biological features of neoplasms: integration of molecular findings. Histopathology 53: 1-19.
29. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC, (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288.
30. Scully RE, Clement PB, Young RH, (2004) Ovarian Surface Epithelial-Stromal Tumors; Mills SE, editor. Philadelphia, PA Lippincott Williams & Wilkins pp. 2543-2578.
31. Naora H, (2007) The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms. Expert Rev Mol Med 9: 1-12.
32. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
33. Schaar DG, Medina DJ, Moore DF, Strair RK, Ting Y, (2009) miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 37: 245-255.
34. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-153.
35. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
36. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
37. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, et al. (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491.
38. Guimbellot JS, Erickson SW, Mehta T, Wen H, Page GP, et al. (2009) Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis. BMC Med Genomics 2: 15.
39. Kuhn DE, Martin MM, Feldman DS, Terry AV Jr, Nuovo GJ, et al. (2008) Experimental validation of miRNA targets. Methods 44: 47-54.
40. Thomas M, Lieberman J, Lal A, (2010) Desperately seeking microRNA targets. Nat Struct Mol Biol 17: 1169-1174.
41. Buick RN, Pullano R, Trent JM, (1985) Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668-3676.
42. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, et al. (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284: 5731-5741.
43. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
44. Pardee AB, (2006) Regulatory molecular biology. Cell Cycle 5: 846-852.
45. Lee YS, Dutta A, (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
46. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
47. Visone R, Croce CM, (2009) MiRNAs and cancer. Am J Pathol 174: 1131-1138.
48. Wiemer EA, (2007) The role of microRNAs in cancer: no small matter. Eur J Cancer 43: 1529-1544.
49. Bartels CL, Tsongalis GJ, (2009) MicroRNAs: novel biomarkers for human cancer. Clin Chem 55: 623-631.
50. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
51. Lee RC, Feinbaum RL, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
52. Wightman B, Ha I, Ruvkun G, (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
53. Djuranovic S, Nahvi A, Green R, (2011) A parsimonious model for gene regulation by miRNAs. Science 331: 550-553.
54. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105: 1608-1613.
55. Vasudevan S, Tong Y, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
56. Ritchie W, Rajasekhar M, Flamant S, Rasko JE, (2009) Conserved expression patterns predict microRNA targets. PLoS Comput Biol 5: e1000513.
57. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB, (2008) MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A 105: 19678-19683.
58. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, et al. (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20: 589-599.
59. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
60. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, et al. (2009) Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res 69: 7548-7556.
61. Koppelstaetter C, Jennings P, Hochegger K, Perco P, Ischia R, et al. (2005) Effect of tissue fixatives on telomere length determination by quantitative PCR. Mech Ageing Dev 126: 1331-1333.
62. Pattyn F, Speleman F, De Paepe A, Vandesompele J, (2003) RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res 31: 122-123.
63. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
64. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
65. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434: 338-345.
66. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96-104.
67. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
68. Mieczkowski J, Tyburczy ME, Dabrowski M, Pokarowski P, (2010) Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements. BMC Bioinformatics 11: 104.
69. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
70. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
71. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
72. Chen K, Rajewsky N, (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38: 1452-1456.
73. Grun D, Wang YL, Langenberger D, Gunsalus KC, Rajewsky N, (2005) microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol 1: e13.
74. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
75. Lall S, Grun D, Krek A, Chen K, Wang YL, et al. (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 16: 460-471.